Evidence map›Paper›PMID 25368024›Full record

ArticleHypertension (Dallas, Tex. : 1979)2015

Variants in striatin gene are associated with salt-sensitive blood pressure in mice and humans.

Amanda E Garza, Chevon M Rariy, Bei Sun, Jonathan Williams, Jessica Lasky-Su, Rene Baudrand, Tham Yao, Burhanuddin Moize, Wan M Hafiz, Jose R Romero and 5 more

Registry-linked trialOpen access · bronzeAbstract read
In one paragraph

Article in Hypertension (Dallas, Tex. : 1979), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03683069 (Hypertension and Striatin Gene Structure Related to Aldo Phenotype), which is not on this map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03683069 phase4completednot on this mapstarted 2019, after this paper: background citation

Hypertension and Striatin Gene Structure Related to Aldo Phenotype

TypeinterventionalSponsorBrigham and Women's HospitalRan2019 to 2024Enrolled90ConditionsHypertension, Genetics HypertensionArmsEplerenone vs Amlodipine
3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 49 citations in OpenAlex.

  1. Article
  2. Targeting PP2A in cancer: an underrated option.Journal of experimental & clinical cancer research : CR · 2025
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. The Effect of Aldosterone on Cardiorenal and Metabolic Systems.International journal of molecular sciences · 2023
    Review
  10. Review
  11. Article
  12. Review
  13. Interplay Between Statins, Cav1 (Caveolin-1), and Aldosterone.Hypertension (Dallas, Tex. : 1979) · 2020 · on this map
    Observational
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 3 institutions in 2 countries.

Amanda E Garza *Division of Endocrinology, Diabetes and Hypertension, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School. Boston, MA 02115, USA.
Chevon M Rariy *Division of Endocrinology, Diabetes and Hypertension, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School. Boston, MA 02115, USA.
Bei SunDivision of Endocrinology, Diabetes and Hypertension, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School. Boston, MA 02115, USA.
Jonathan WilliamsDivision of Endocrinology, Diabetes and Hypertension, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School. Boston, MA 02115, USA.
Jessica Lasky-SuChanning Department of Network Medicine, Brigham and Women's Hospital, Harvard Medical School. Boston, MA 02115, USA.
Rene BaudrandDivision of Endocrinology, Diabetes and Hypertension, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School. Boston, MA 02115, USA.
Tham YaoDivision of Endocrinology, Diabetes and Hypertension, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School. Boston, MA 02115, USA.
Burhanuddin MoizeDivision of Endocrinology, Diabetes and Hypertension, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School. Boston, MA 02115, USA.
Wan M HafizDivision of Endocrinology, Diabetes and Hypertension, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School. Boston, MA 02115, USA.
Jose R RomeroDivision of Endocrinology, Diabetes and Hypertension, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School. Boston, MA 02115, USA.
Gail K AdlerDivision of Endocrinology, Diabetes and Hypertension, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School. Boston, MA 02115, USA.
Claudio FerriDivision of Internal Medicine & Nephrology and School of Internal Medicine, University of L'Aquila - San Salvatore Hospital, V.le San Salvatore - Delta 6 Building, Coppito 67100 AQ, Italy.
Paul N HopkinsDivision of Cardiovascular Genetics, University of Utah School of Medicine, Salt Lake City, UT 84108.
Luminita H PojogaDivision of Endocrinology, Diabetes and Hypertension, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School. Boston, MA 02115, USA.
Gordon H WilliamsDivision of Endocrinology, Diabetes and Hypertension, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School. Boston, MA 02115, USA.
San Salvatore Hospital · ITUniversity of L'Aquila · ITPontificia Universidad Católica de Chile · CL

Funding

SCOR MOLECULAR GENETICS OF HYPERTENSIONP50HL055000 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI LEPPERT, MARK F · 1996 to 2005
$13.5M
TRAINING PROGRAM IN HYPERTENSIONT32HL007609 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI ADLER, GAIL KURR · 1985 to 2022
$10.2M
Striatin, Aldosterone and HypertensionR01HL114765 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI GARZA, AMANDA ELIZABETH, WILLIAMS, GORDON H · 2013 to 2017
$4.3M
Genetics of Human HypertensionR01HL086907 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI WILLIAMS, GORDON H · 2007 to 2011
$3.5M
Caveolin-1 and vascular dysfunctionR01HL104032 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI POJOGA, LUMINITA · 2010 to 2014
$2.1M
Aldosteron, Intracellular Leukocyte Magnesium and Inflammation in DiabetesR01HL096518 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI ROMERO, JOSE R · 2009 to 2012
$1.9M
Mechanisms of Aldosterone Induced Cardiovascular DamageR01HL069208 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI WILLIAMS, GORDON H · 2003 to 2006
$1.8M
Aldosterone and Diabetic Cardiovascular Disease: Research and Mentoring ProgamK24HL103845 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI ADLER, GAIL KURR · 2011 to 2021
$1.6M
Aldosterone, Histone Demethylase and Cardiovascular DiseaseR01HL094452 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI WILLIAMS, GORDON H · 2009 to 2010
$1.3M
GENETICS OF HYPERTENSIONR01HL047651 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI WILLIAMS, GORDON H · 1992 to 1995
–
NHLBI NIH HHS K24 HL103845NHLBI NIH HHS P50 HL055000NHLBI NIH HHS P50HL055000NHLBI NIH HHS R01 HL047651NHLBI NIH HHS R01 HL069208NHLBI NIH HHS R01 HL086907NHLBI NIH HHS R01 HL094452NHLBI NIH HHS R01 HL096518NHLBI NIH HHS R01HL096518NHLBI NIH HHS R01 HL104032NHLBI NIH HHS R01HL104032NHLBI NIH HHS R01HL11476NHLBI NIH HHS R01 HL114765NHLBI NIH HHS T32 HL007609NHLBI NIH HHS T32HL007609-27
6 · The paper itself

Abstract

Striatin is a novel protein that interacts with steroid receptors and modifies rapid, nongenomic activity in vitro. We tested the hypothesis that striatin would in turn affect mineralocorticoid receptor function and consequently sodium, water, and blood pressure homeostasis in an animal model. We evaluated salt sensitivity of blood pressure in novel striatin heterozygote knockout mice. Compared with wild type, striatin heterozygote exhibited a significant increase in blood pressure when sodium intake was increased from restricted (0.03%) to liberal (1.6%) sodium. Furthermore, renal expression of mineralocorticoid receptor and its genomic downstream targets serum/glucocorticoid-regulated kinase 1, and epithelial sodium channel was increased in striatin heterozygote versus wild-type mice on liberal sodium intake while the pAkt/Akt ratio, readout of mineralocorticoid receptor's rapid, nongenomic pathway, was reduced. To determine the potential clinical relevance of these findings, we tested the association between single nucleotide polymorphic variants of striatin gene and salt sensitivity of blood pressure in 366 white hypertensive subjects. HapMap-derived tagging single nucleotide polymorphisms identified an association of rs2540923 with salt sensitivity of blood pressure (odds ratio, 6.25; 95% confidence interval, 1.7-20; P=0.01). These data provide the first in vivo evidence in humans and rodents that associates striatin with markers of mineralocorticoid receptor activity. The data also support the hypothesis that the rapid, nongenomic mineralocorticoid receptor pathway (mediated via striatin) has a role in modulating the interaction between salt intake and blood pressure.

Indexed as

Gene Expression RegulationAnimalsBlood PressureBlotting, WesternCalmodulin-Binding ProteinsDisease Models, AnimalGenotypeHumansHypertensionMembrane ProteinsMiceMice, KnockoutNerve Tissue ProteinsPhenotypePolymerase Chain ReactionRNA, MessengerCalmodulin-Binding ProteinsMembrane ProteinsNerve Tissue ProteinsRNA, MessengerSodium, DietarySTRN protein, humanStrn protein, mouseblood pressurepolymorphism, single nucleotidestriatin protein, mouse

Identifiers

PMID25368024
PMCPMC4617687
OpenAlexW1964626513

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.